Welcome to our dedicated page for HEALTHSTREAM SEC filings (Ticker: HSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HEALTHSTREAM's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HEALTHSTREAM's regulatory disclosures and financial reporting.
HealthStream reported record second-quarter 2026 revenue of $83.7 million, up 12.5% from the second quarter of 2025, with net income of $6.7 million and diluted EPS of $0.23. Adjusted EBITDA rose to $20.6 million, up 16.9%, as operating income increased 41.4% to $8.3 million.
For the first six months of 2026, revenue grew to $164.9 million and net income to $12.6 million, with adjusted EBITDA of $40.7 million. At June 30, 2026, cash, cash equivalents, and marketable securities totaled $66.7 million, and the company had no outstanding indebtedness from borrowed money.
The board declared a quarterly dividend of $0.035 per share, payable August 28, 2026, and the company repurchased 432,476 shares in the first half of 2026 for $9.3 million. Full-year 2026 guidance was updated to revenue of $327.0–$332.0 million, net income of $19.5–$22.2 million, adjusted EBITDA of $74.0–$78.0 million, and capital expenditures of $31.0–$34.0 million.
HealthStream, Inc. reported a cybersecurity incident in which an unauthorized third party accessed a limited portion of files on its corporate file servers. Based on the company’s investigation so far, customer-facing systems were not accessed or compromised, no protected health information under HIPAA has been identified as accessed or exfiltrated, and no files were encrypted. Product and service delivery and other business operations have continued without interruption.
The company believes certain employee information, billing-related information for some customers and vendors, and corporate and legal information were accessed and/or exfiltrated. Data for approximately 75 credentialing customers had been copied to the corporate file servers for conversion, analytics, and troubleshooting, and those customers have been notified. HealthStream has engaged cybersecurity and forensics specialists, informed law enforcement, and expects to incur expenses for response, remediation, and investigation. Based on information currently known, it does not expect a material adverse impact on its business, operations, or financial results.
Dimensional Fund Advisors LP, a Delaware limited partnership and registered investment adviser, reports beneficial ownership of 1,557,981 shares of HealthStream Inc common stock, representing 5.3% of the class. Dimensional has sole voting power over 1,522,834 shares and sole dispositive power over 1,557,981 shares, with no shared voting or dispositive power. All shares are owned by underlying investment funds and accounts for which Dimensional or its subsidiaries provide advisory or management services, and Dimensional states that it disclaims beneficial ownership of these securities other than for purposes of Section 13(d) of the Securities Exchange Act of 1934. The funds, rather than Dimensional, are entitled to dividends and sale proceeds, and Dimensional indicates that no single fund holds more than 5% of the class.
HEALTHSTREAM INC director Linda Rebrovick reported an open-market sale of 6,000 shares of common stock on July 6, 2026 at a price of $29.00 per share. After this transaction, she directly holds 51,329 shares of HealthStream stock. The sale was carried out under a pre-arranged Rule 10b5-1 sales plan adopted on November 21, 2025, indicating the trade was scheduled in advance rather than timed discretionarily.
HSTM submitted a Form 144 notifying the proposed sale of 6,000 shares of Common Stock. The filing lists the securities as issued under a Stock Award dated 04/26/2016. The filing also reports completed dispositions of 2,000 shares on 05/28/2026 and 2,000 shares on 06/01/2026, each showing proceeds of $50,000.00.
HealthStream Inc. director Charles Jr. Beard reported acquiring 1,249 shares of common stock through the vesting and conversion of restricted share units (RSUs). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs follow a three-year vesting schedule, contingent on continued service, and will vest annually in three equal installments beginning on May 29, 2026. After this transaction, Beard directly holds 1,249 shares of common stock and 2,500 RSUs.
HEALTHSTREAM INC director Dent Thompson increased his direct equity stake through equity compensation. On June 8, 2026, he acquired 3,148 shares of common stock at $0.00 per share upon vesting and conversion of restricted share units. Following these transactions, he directly holds 139,975 common shares.
HealthStream Inc. director Amir Alex Jahangir increased his equity stake through RSU vesting. On June 8, 2026, he acquired 3,148 shares of common stock upon the exercise of restricted share units, bringing his direct common stock holdings to 6,405 shares.
The filing shows multiple RSU awards, each representing the right to receive one share of common stock upon vesting. These RSUs follow three-year vesting schedules beginning on June 6, 2024, May 30, 2025, and May 29, 2026, contingent on continued service.
HEALTHSTREAM INC director Jeffrey L. McLaren reported acquiring shares through the vesting of restricted share units (RSUs). On June 8, 2026, RSU awards vested and delivered 3,148 shares of common stock, reflecting compensation rather than open‑market buying or selling.
Following these conversions, McLaren directly holds 25,748 shares of common stock and 2,032 RSUs. Each RSU represents a contingent right to receive one share of common stock upon vesting and is subject to a three‑year vesting schedule that requires continued service, with installments beginning on specific June and May dates in 2024, 2025, and 2026.